Lenalidomide may delay onset of myeloma-related bone, organ damage

The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage. Results of the study, which was conducted by the Eastern Cooperative Oncology Group and funded by the National Cancer Institute, were published Friday, Oct. 25, in the Journal of Clinical Oncology. “Our […]

Read more

Bone erosions more frequent with old age at onset of early RA

(HealthDay)—Old age at onset of early rheumatoid arthritis (RA) is associated with more frequent bone erosions, according to a study published online Nov. 11 in the International Journal of Rheumatic Diseases. Koichi Murata, from Kyoto University in Japan, and colleagues examined how old age at disease onset affects treatment and prognosis in early RA using data from the Kyoto Rheumatoid […]

Read more